AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
We depend on the Hackaday community to help us find all the fresh hacks the Internet has to offer. Whenever you see something you think should be discussed on Hackaday we want to hear from you. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results